<?xml version="1.0"?>
<presentation title="07 Dongwook Oh" width="792.0000000" height="612.0000000" thmbWidth="76.0000000" thmbHeight="59.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{62AAC587-4B3A-40FC-9E24-A52FFB53F2E5}">
	<presenters>
		<presenter name="Dongwook Oh" title="Korea" email="" web="" phone="" photoAssetId="">
			<bio>EUS-FNA/B &amp; CE-EUS guided FNA of hepatic lesions</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets>
		<soundAsset id="sndAsset0" src="sound1.mp3" embedded="0" size="152809" duration="19101"/>
		<soundAsset id="sndAsset1" src="sound2.mp3" embedded="0" size="139434" duration="17429"/>
		<soundAsset id="sndAsset2" src="sound3.mp3" embedded="0" size="77158" duration="9644"/>
		<soundAsset id="sndAsset3" src="sound4.mp3" embedded="0" size="163049" duration="20381"/>
		<soundAsset id="sndAsset4" src="sound5.mp3" embedded="0" size="82173" duration="10271"/>
		<soundAsset id="sndAsset5" src="sound6.mp3" embedded="0" size="132120" duration="16515"/>
		<soundAsset id="sndAsset6" src="sound7.mp3" embedded="0" size="294706" duration="36838"/>
		<soundAsset id="sndAsset7" src="sound8.mp3" embedded="0" size="120208" duration="15026"/>
		<soundAsset id="sndAsset8" src="sound9.mp3" embedded="0" size="236609" duration="29576"/>
		<soundAsset id="sndAsset9" src="sound10.mp3" embedded="0" size="311633" duration="38954"/>
		<soundAsset id="sndAsset10" src="sound11.mp3" embedded="0" size="271509" duration="33938"/>
		<soundAsset id="sndAsset11" src="sound12.mp3" embedded="0" size="156152" duration="19519"/>
		<soundAsset id="sndAsset12" src="sound13.mp3" embedded="0" size="345279" duration="43159"/>
		<soundAsset id="sndAsset13" src="sound14.mp3" embedded="0" size="257925" duration="32240"/>
		<soundAsset id="sndAsset14" src="sound15.mp3" embedded="0" size="299303" duration="37412"/>
		<soundAsset id="sndAsset15" src="sound16.mp3" embedded="0" size="201292" duration="25161"/>
		<soundAsset id="sndAsset16" src="sound17.mp3" embedded="0" size="323336" duration="40417"/>
		<soundAsset id="sndAsset17" src="sound18.mp3" embedded="0" size="114147" duration="14268"/>
		<soundAsset id="sndAsset18" src="sound19.mp3" embedded="0" size="80502" duration="10062"/>
		<soundAsset id="sndAsset19" src="sound20.mp3" embedded="0" size="331068" duration="41383"/>
		<soundAsset id="sndAsset20" src="sound21.mp3" embedded="0" size="419676" duration="52459"/>
		<soundAsset id="sndAsset21" src="sound22.mp3" embedded="0" size="58768" duration="7346"/>
		<soundAsset id="sndAsset22" src="sound23.mp3" embedded="0" size="290526" duration="36315"/>
		<soundAsset id="sndAsset23" src="sound24.mp3" embedded="0" size="209024" duration="26128"/>
		<soundAsset id="sndAsset24" src="sound25.mp3" embedded="0" size="209442" duration="26180"/>
		<soundAsset id="sndAsset25" src="sound26.mp3" embedded="0" size="262523" duration="32815"/>
		<soundAsset id="sndAsset26" src="sound27.mp3" embedded="0" size="90324" duration="11290"/>
		<soundAsset id="sndAsset27" src="sound28.mp3" embedded="0" size="195231" duration="24403"/>
		<soundAsset id="sndAsset28" src="sound29.mp3" embedded="0" size="153853" duration="19231"/>
		<soundAsset id="sndAsset29" src="sound30.mp3" embedded="0" size="327725" duration="40965"/>
		<soundAsset id="sndAsset30" src="sound31.mp3" embedded="0" size="523956" duration="65494"/>
		<soundAsset id="sndAsset31" src="sound32.mp3" embedded="0" size="102236" duration="12779"/>
		<soundAsset id="sndAsset32" src="sound33.mp3" embedded="0" size="134209" duration="16776"/>
		<soundAsset id="sndAsset33" src="sound34.mp3" embedded="0" size="191888" duration="23986"/>
		<soundAsset id="sndAsset34" src="sound35.mp3" embedded="0" size="210696" duration="26337"/>
	</soundAssets>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
		<graphicAsset id="imgAsset18" src="thmb19.swf" embedded="0"/>
		<graphicAsset id="imgAsset19" src="thmb20.swf" embedded="0"/>
		<graphicAsset id="imgAsset20" src="thmb21.swf" embedded="0"/>
		<graphicAsset id="imgAsset21" src="thmb22.swf" embedded="0"/>
		<graphicAsset id="imgAsset22" src="thmb23.swf" embedded="0"/>
		<graphicAsset id="imgAsset23" src="thmb24.swf" embedded="0"/>
		<graphicAsset id="imgAsset24" src="thmb25.swf" embedded="0"/>
		<graphicAsset id="imgAsset25" src="thmb26.swf" embedded="0"/>
		<graphicAsset id="imgAsset26" src="thmb27.swf" embedded="0"/>
		<graphicAsset id="imgAsset27" src="thmb28.swf" embedded="0"/>
		<graphicAsset id="imgAsset28" src="thmb29.swf" embedded="0"/>
		<graphicAsset id="imgAsset29" src="thmb30.swf" embedded="0"/>
		<graphicAsset id="imgAsset30" src="thmb31.swf" embedded="0"/>
		<graphicAsset id="imgAsset31" src="thmb32.swf" embedded="0"/>
		<graphicAsset id="imgAsset32" src="thmb33.swf" embedded="0"/>
		<graphicAsset id="imgAsset33" src="thmb34.swf" embedded="0"/>
		<graphicAsset id="imgAsset34" src="thmb35.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<audioTracks>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset0">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="19.0590000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset1">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="17.3920000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset2">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="9.6099997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset3">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="20.3290000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset4">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="10.2279997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset5">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="16.4629993"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset6">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="36.7980000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset7">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="14.9930000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset8">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="29.5370000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset9">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="38.9049988"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset10">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="33.8820000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset11">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="19.4659996"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset12">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="43.1189995"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset13">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="32.1879997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset14">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="37.3600000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset15">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="25.1140000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset16">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="40.3610000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset17">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="14.2340000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset18">
				<startTimestamp slideIndex="18" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="18" stepIndex="0" timeOffset="10.0089998"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset19">
				<startTimestamp slideIndex="19" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="19" stepIndex="0" timeOffset="41.3419991"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset20">
				<startTimestamp slideIndex="20" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="20" stepIndex="0" timeOffset="52.4109993"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset21">
				<startTimestamp slideIndex="21" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="21" stepIndex="0" timeOffset="7.2900000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset22">
				<startTimestamp slideIndex="22" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="22" stepIndex="0" timeOffset="36.2700000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset23">
				<startTimestamp slideIndex="23" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="23" stepIndex="0" timeOffset="26.0780000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset24">
				<startTimestamp slideIndex="24" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="24" stepIndex="0" timeOffset="26.1420000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset25">
				<startTimestamp slideIndex="25" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="25" stepIndex="0" timeOffset="32.7690000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset26">
				<startTimestamp slideIndex="26" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="26" stepIndex="0" timeOffset="11.2480000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset27">
				<startTimestamp slideIndex="27" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="27" stepIndex="0" timeOffset="24.3479996"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset28">
				<startTimestamp slideIndex="28" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="28" stepIndex="0" timeOffset="19.1940000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset29">
				<startTimestamp slideIndex="29" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="29" stepIndex="0" timeOffset="40.9300000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset30">
				<startTimestamp slideIndex="30" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="30" stepIndex="0" timeOffset="65.4570000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset31">
				<startTimestamp slideIndex="31" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="31" stepIndex="0" timeOffset="12.7279997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset32">
				<startTimestamp slideIndex="32" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="32" stepIndex="0" timeOffset="16.7430000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset33">
				<startTimestamp slideIndex="33" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="33" stepIndex="0" timeOffset="23.9290000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset34">
				<startTimestamp slideIndex="34" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="34" stepIndex="0" timeOffset="26.2880000"/>
			</audioTrack>
		</audioTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="false"/>
					<button type="presenterInfo" visible="false"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>true</showPresenterInfo>
				<showPresenterVideo>false</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>false</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="never"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="EUS-FNA/B &amp; CE-EUS guided FNA of hepatic lesions" titleNormalized="eus-fna/b &amp; ce-eus guided fna of hepatic lesions" src="slide1.swf" size="2449" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.0580000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-FNA/B &amp; CE-EUS guided FNA of hepatic lesions
 Dongwook Oh, MD
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine</text>
		</slide>
		<slide index="1" title="Expanding indications for EUS &amp; contrast enhanced harmonic EUS (CE-EUS)" titleNormalized="expanding indications for eus &amp; contrast enhanced harmonic eus (ce-eus)" src="slide2.swf" size="3500" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="17.3910002"/>
			</animationSteps>
			<notes>To date, most reports about CH EUS have been related to pancreatic mass
The emerging indication would be hepatobiliary lesion</notes>
			<notesNormalized>to date, most reports about ch eus have been related to pancreatic mass
the emerging indication would be hepatobiliary lesion</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;To date, most reports about CH EUS have been related to pancreatic mass&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The emerging indication would be hepatobiliary lesion&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Expanding indications for EUS &amp; contrast enhanced harmonic EUS (CE-EUS)


EUS-FNA/B of hepatic lesions
CE-EUS for evaluation and guidance of hepatic lesions 
 
 
Beyond pancreas!</text>
		</slide>
		<slide index="2" title="Expanding indications for EUS &amp; contrast enhanced harmonic EUS (CE-EUS)" titleNormalized="expanding indications for eus &amp; contrast enhanced harmonic eus (ce-eus)" src="slide3.swf" size="3218" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="9.6089997"/>
			</animationSteps>
			<notes>To date, most reports about CH EUS have been related to pancreatic mass
The emerging indication would be hepatobiliary lesion</notes>
			<notesNormalized>to date, most reports about ch eus have been related to pancreatic mass
the emerging indication would be hepatobiliary lesion</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;To date, most reports about CH EUS have been related to pancreatic mass&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The emerging indication would be hepatobiliary lesion&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Expanding indications for EUS &amp; contrast enhanced harmonic EUS (CE-EUS)


EUS-FNA/B of hepatic lesions
CE-EUS for evaluation and guidance of hepatic lesions 
 
</text>
		</slide>
		<slide index="3" title="Background" titleNormalized="background" src="slide4.swf" size="17640" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.3280005"/>
			</animationSteps>
			<notes>The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.

Small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.

Although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients. </notes>
			<notesNormalized>the diagnosis of hepatic lesions has been traditionally accomplished by ct or us guidance.

small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.

although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Small lesions (&amp;lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Background
The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.

Small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach. 

Endosc Ultrasound. 2015
Am J Gastroenterol. 2003
Gastroenterology. 1990
</text>
		</slide>
		<slide index="4" title="Liver anatomy" titleNormalized="liver anatomy" src="slide5.swf" size="33363" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="10.2269997"/>
			</animationSteps>
			<notes>The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.

Small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.

Although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients. </notes>
			<notesNormalized>the diagnosis of hepatic lesions has been traditionally accomplished by ct or us guidance.

small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.

although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Small lesions (&amp;lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Liver anatomy</text>
		</slide>
		<slide index="5" title="Technique of EUS-FNA" titleNormalized="technique of eus-fna" src="slide6.swf" size="40311" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="16.4619993"/>
			</animationSteps>
			<notes>The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.

Small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.

Although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients. </notes>
			<notesNormalized>the diagnosis of hepatic lesions has been traditionally accomplished by ct or us guidance.

small lesions (&lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.

although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The diagnosis of hepatic lesions has been traditionally accomplished by CT or US guidance.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Small lesions (&amp;lt;2 cm) and those that are difficult to differentiate from the background parenchyma are not easily accessible by percutaneous approach.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Although rare, complications from biopsy may include severe bleeding and implantation metastases in up to 3% of patients. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Technique of EUS-FNA</text>
		</slide>
		<slide index="6" title="Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions" titleNormalized="endoscopic ultrasound (eus) and eus-guided fine-needle aspiration (fna) of liver lesions" src="slide7.swf" size="26777" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="36.7970003"/>
			</animationSteps>
			<notes>응우엔 reported that  usefulness of EUS for evaluation of small hepatic lesions.
574 patients with GI and lung cancer underwent EUS for liver evaluation.
14 patients (2.4%) with focal liver lesions on EUS
Before EUS, CT depicted liver lesions in only 3 of 14 (21%) patients.
EUS can detect small focal liver lesions that are not detected at CT.</notes>
			<notesNormalized>응우엔 reported that usefulness of eus for evaluation of small hepatic lesions.
574 patients with gi and lung cancer underwent eus for liver evaluation.
14 patients (2.4%) with focal liver lesions on eus
before eus, ct depicted liver lesions in only 3 of 14 (21%) patients.
eus can detect small focal liver lesions that are not detected at ct.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;응우엔 reported that  usefulness of EUS for evaluation of small hepatic lesions.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;574 patients with GI and lung cancer underwent EUS for liver evaluation.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;14 patients (2.4%) with focal liver lesions on EUS&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Before EUS, CT depicted liver lesions in only 3 of 14 (21%) patients.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;EUS can detect small focal liver lesions that are not detected at CT.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>574 patients with GI and lung cancer
14 patients (2.4%) with focal liver lesions on EUS
Before EUS, CT depicted liver lesions in only 3 of 14 (21%) patients.


Gastrointest Endosc 1990</text>
		</slide>
		<slide index="7" title="Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions" titleNormalized="endoscopic ultrasound (eus) and eus-guided fine-needle aspiration (fna) of liver lesions" src="slide8.swf" size="73526" advanceOnTime="1" framesCount="155" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="154" playTime="6.4166667" pauseTime="8.5763334"/>
			</animationSteps>
			<notes>응우엔 reported that  usefulness of EUS for evaluation of small hepatic lesions.
574 patients with GI and lung cancer underwent EUS for liver evaluation.
14 patients (2.4%) with focal liver lesions on EUS
Before EUS, CT depicted liver lesions in only 3 of 14 (21%) patients.
EUS can detect small focal liver lesions that are not detected at CT.</notes>
			<notesNormalized>응우엔 reported that usefulness of eus for evaluation of small hepatic lesions.
574 patients with gi and lung cancer underwent eus for liver evaluation.
14 patients (2.4%) with focal liver lesions on eus
before eus, ct depicted liver lesions in only 3 of 14 (21%) patients.
eus can detect small focal liver lesions that are not detected at ct.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;응우엔 reported that  usefulness of EUS for evaluation of small hepatic lesions.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;574 patients with GI and lung cancer underwent EUS for liver evaluation.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;14 patients (2.4%) with focal liver lesions on EUS&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Before EUS, CT depicted liver lesions in only 3 of 14 (21%) patients.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;EUS can detect small focal liver lesions that are not detected at CT.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Gastrointest Endosc 1990
EUS can detect small focal liver lesions that are not detected at CT

With EUS-FNA, it is possible to make a cytologic diagnosis of small liver metastasis
</text>
		</slide>
		<slide index="8" title="Endoscopic Ultrasound Versus CT Scan for Detection of the Metastases to the liver" titleNormalized="endoscopic ultrasound versus ct scan for detection of the metastases to the liver" src="slide9.swf" size="3158" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="29.5360007"/>
			</animationSteps>
			<notes>132 patients with GI and lung cancer
26 patients (19.7%) were identified with liver metastasis

EUS proved to be superior to CT scan in diagnostic accuracy, 98% compared to 92%.
In its ability to detect the number of metastatic lesions in the liver, 40 compared to 19, respectively, (P = 0.008).

In comparison with the CT scan, there was trend in favor of EUS/EUS-FNA for the superior diagnostic accuracy. EUS
was distinctly superior to the CT scan in detecting the number of metastatic lesions. EUS-FNA was also useful to
identify the nature of lesions that were too small to be characterized on the CT scan.</notes>
			<notesNormalized>132 patients with gi and lung cancer
26 patients (19.7%) were identified with liver metastasis

eus proved to be superior to ct scan in diagnostic accuracy, 98% compared to 92%.
in its ability to detect the number of metastatic lesions in the liver, 40 compared to 19, respectively, (p = 0.008).

in comparison with the ct scan, there was trend in favor of eus/eus-fna for the superior diagnostic accuracy. eus
was distinctly superior to the ct scan in detecting the number of metastatic lesions. eus-fna was also useful to
identify the nature of lesions that were too small to be characterized on the ct scan.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;&lt;b&gt;132 patients with GI and lung cancer&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;b&gt;26 patients (19.7%) were identified with liver metastasis&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;b&gt;EUS proved to be superior to CT scan in diagnostic accuracy, 98% compared to 92%.&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In its ability to detect the number of metastatic lesions in the liver, 40 compared to 19, respectively, (P = 0.008).&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In comparison with the CT scan, there was trend in favor of EUS/EUS-FNA for the superior diagnostic accuracy. EUS&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;was distinctly superior to the CT scan in detecting the number of metastatic lesions. EUS-FNA was also useful to&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;identify the nature of lesions that were too small to be characterized on the CT scan.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>
132 patients with GI and lung cancer
26 patients (19.7%) were identified with liver metastasis
EUS was superior to CT scan in diagnostic accuracy, 98% compared to 92% (P = 0.0578)
J Clin Gastroenterol 2009</text>
		</slide>
		<slide index="9" title="Endoscopic Ultrasound Versus CT Scan for Detection of the Metastases to the liver" titleNormalized="endoscopic ultrasound versus ct scan for detection of the metastases to the liver" src="slide10.swf" size="2817" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="38.9039988"/>
			</animationSteps>
			<notes>132 patients with GI and lung cancer
26 patients (19.7%) were identified with liver metastasis

EUS proved to be superior to CT scan in diagnostic accuracy, 98% compared to 92%.
In its ability to detect the number of metastatic lesions in the liver, 40 compared to 19, respectively, (P = 0.008).

In comparison with the CT scan, there was trend in favor of EUS/EUS-FNA for the superior diagnostic accuracy. EUS
was distinctly superior to the CT scan in detecting the number of metastatic lesions. EUS-FNA was also useful to
identify the nature of lesions that were too small to be characterized on the CT scan.</notes>
			<notesNormalized>132 patients with gi and lung cancer
26 patients (19.7%) were identified with liver metastasis

eus proved to be superior to ct scan in diagnostic accuracy, 98% compared to 92%.
in its ability to detect the number of metastatic lesions in the liver, 40 compared to 19, respectively, (p = 0.008).

in comparison with the ct scan, there was trend in favor of eus/eus-fna for the superior diagnostic accuracy. eus
was distinctly superior to the ct scan in detecting the number of metastatic lesions. eus-fna was also useful to
identify the nature of lesions that were too small to be characterized on the ct scan.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;&lt;b&gt;132 patients with GI and lung cancer&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;b&gt;26 patients (19.7%) were identified with liver metastasis&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;b&gt;EUS proved to be superior to CT scan in diagnostic accuracy, 98% compared to 92%.&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In its ability to detect the number of metastatic lesions in the liver, 40 compared to 19, respectively, (P = 0.008).&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In comparison with the CT scan, there was trend in favor of EUS/EUS-FNA for the superior diagnostic accuracy. EUS&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;was distinctly superior to the CT scan in detecting the number of metastatic lesions. EUS-FNA was also useful to&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;identify the nature of lesions that were too small to be characterized on the CT scan.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>
EUS detected significantly higher number of metastatic lesions in the liver (40 vs.19; P = 0.008).
In 8 cases, CT detected lesions that were too small to characterize, of which EUS-FNA correctly diagnosed 4 cases to be malignant and 4 cases to be benign. 
J Clin Gastroenterol 2009</text>
		</slide>
		<slide index="10" title="" titleNormalized="" src="slide11.swf" size="109677" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="33.8810000"/>
			</animationSteps>
			<notes>EUS-FNB with core biopsy needle for solid liver mass may be helpful in the
management of patients who are unable to diagnose using percutaneous liver biopsy.</notes>
			<notesNormalized>eus-fnb with core biopsy needle for solid liver mass may be helpful in the
management of patients who are unable to diagnose using percutaneous liver biopsy.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;EUS-FNB with core biopsy needle for solid liver mass may be helpful in the&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;management of patients who are unable to diagnose using percutaneous liver biopsy.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>J Gastroenterol Hepatol 2015</text>
		</slide>
		<slide index="11" title="Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass" titleNormalized="endoscopic ultrasound-guided fine-needle aspiration can target right liver mass" src="slide12.swf" size="29205" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.4649996"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Between Sep 2010 and July 2016
A single center retrospective study
Clinical utility of EUS-FNA for hepatic lesions
47 consecutive pts with hepatic masses underwent EUS-FNA
</text>
		</slide>
		<slide index="12" title="RESULTS (I)" titleNormalized="results (i)" src="slide13.swf" size="11479" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="43.1179995"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>RESULTS (I)
Characteristics
N = 47
Site of biopsy, n (%)
 Left lobe
30 (63.8) 
 Right lobe
17 (36.2) 
Size of lesion on EUS, median, mm (IQR)
26 (15–37)
Indications for EUS‑FNA, n (%) 
 Concurrent FNA for pancreatic and liver lesions
16 (34)
 EUS‑FNA after failure of percutaneous liver biopsy 
13 (27.7) 
 Liver mass to assess primary lesion 
12 (25.5) 
 Contraindication of percutaneous liver biopsy due to 
 advanced liver cirrhosis 
6 (12.8) 
Number of needle passes, median (IQR) 
3 (3–4)
Technical success, n (%)
46 (97.9)
Sample adequacy, n (%)
42/46 (91.3)
Diagnostic accuracy, n (%)
38 (80.9)
Adverse events, n (%)
0</text>
		</slide>
		<slide index="13" title="RESULTS (II)" titleNormalized="results (ii)" src="slide14.swf" size="15555" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="32.1869997"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>RESULTS (II)</text>
		</slide>
		<slide index="14" title="One session of EUS-FNA for suspected pancreatic lesions and liver lesions" titleNormalized="one session of eus-fna for suspected pancreatic lesions and liver lesions" src="slide15.swf" size="92638" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="37.3590006"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>One session of EUS-FNA for suspected pancreatic lesions and liver lesions</text>
		</slide>
		<slide index="15" title="Case : M/71" titleNormalized="case : m/71" src="slide16.swf" size="5800" advanceOnTime="1" framesCount="342" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="341" playTime="14.2083333" pauseTime="10.9056670"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Case : M/71
Unusual inflammatory mass or malignancy</text>
		</slide>
		<slide index="16" title="Case : M/71" titleNormalized="case : m/71" src="slide17.swf" size="102404" advanceOnTime="1" framesCount="971" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video0" videoClipId="ispring.resources_1794db30.spr0_5219731" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_1794db30.spr2_5219731" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video0" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="970" playTime="40.3610001" pauseTime="0.0000000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="17" title="Case : M/71" titleNormalized="case : m/71" src="slide18.swf" size="1900" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="14.2330002"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Case : M/71
Chronic granulomatous inflammation with caseous necrosis</text>
		</slide>
		<slide index="18" title="F/50" titleNormalized="f/50" src="slide19.swf" size="68889" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset18" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="10.0079998"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>F/50</text>
		</slide>
		<slide index="19" title="EUS-FNA of S5 S6 mass" titleNormalized="eus-fna of s5 s6 mass" src="slide20.swf" size="247254" advanceOnTime="1" framesCount="995" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset19" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video1" videoClipId="ispring.resources_17c6a580.spr0_5235003" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_17c6a580.spr2_5235003" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video1" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="994" playTime="41.3419991" pauseTime="0.0000000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="20" title="Limitation of EUS-FNA/B" titleNormalized="limitation of eus-fna/b" src="slide21.swf" size="18274" advanceOnTime="1" framesCount="922" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset20" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="921" playTime="38.3750000" pauseTime="14.0359993"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Limitation of EUS-FNA/B 
Difficult to get anatomical orientation
Penetration depth
Angulation of scope tip

A thorough understanding of the liver anatomy is prerequisite for successful EUS-FNA/B for hepatic lesions</text>
		</slide>
		<slide index="21" title="Expanding indications for EUS &amp; contrast enhanced harmonic EUS (CE-EUS)" titleNormalized="expanding indications for eus &amp; contrast enhanced harmonic eus (ce-eus)" src="slide22.swf" size="3221" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset21" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="7.2990002"/>
			</animationSteps>
			<notes>To date, most reports about CH EUS have been related to pancreatic mass
The emerging indication would be hepatobiliary lesion</notes>
			<notesNormalized>to date, most reports about ch eus have been related to pancreatic mass
the emerging indication would be hepatobiliary lesion</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;To date, most reports about CH EUS have been related to pancreatic mass&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The emerging indication would be hepatobiliary lesion&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Expanding indications for EUS &amp; contrast enhanced harmonic EUS (CE-EUS)


EUS-FNA/B of hepatic lesions
CE-EUS for evaluation and guidance of hepatic lesions 
 
</text>
		</slide>
		<slide index="22" title="SonoVueTM vs SonazoidTM" titleNormalized="sonovuetm vs sonazoidtm" src="slide23.swf" size="14980" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset22" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="36.2690005"/>
			</animationSteps>
			<notes>Two kinds of second generation agents including SONOVUE and SONAZOID are available in Korea.
Two agents are equivalent for detectability of arterial vascularity
Sonazoid  is phagocytosed by Kupffer cells in liver which enables Kupffer cell image persistent and stable image enhancement</notes>
			<notesNormalized>two kinds of second generation agents including sonovue and sonazoid are available in korea.
two agents are equivalent for detectability of arterial vascularity
sonazoid is phagocytosed by kupffer cells in liver which enables kupffer cell image persistent and stable image enhancement</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Two kinds of second generation agents including SONOVUE and SONAZOID are available in Korea.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Two agents are equivalent for detectability of arterial vascularity&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Sonazoid  is phagocytosed by Kupffer cells in liver which enables Kupffer cell image persistent and stable image enhancement&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>SonoVueTM vs SonazoidTM
Detectability of arterial vascularity
Both, equivalent (for evaluation of pancreas)
Kupffer cell image of Sonazoid
Phagocytosed by Kupffer cells in liver
Kupffer cell activity: related to differentiation
Persistent and stable image enhancement
Preferable for evaluation of liver lesion</text>
		</slide>
		<slide index="23" title="Kupffer Cell Image in CE-EUS" titleNormalized="kupffer cell image in ce-eus" src="slide24.swf" size="47675" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset23" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="26.2210001"/>
			</animationSteps>
			<notes>	Sonazoid persist longer in the liver parenchyma compared to pancreas
	Prolonged visualization of malignant nodules-&gt; inte
	Vascular, kupffer
	rvention guidance for liver lesions</notes>
			<notesNormalized>	sonazoid persist longer in the liver parenchyma compared to pancreas
	prolonged visualization of malignant nodules-&gt; inte
	vascular, kupffer
	rvention guidance for liver lesions</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="24"&gt;	&lt;b&gt;Sonazoid persist longer in the liver parenchyma compared to pancreas&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="24"&gt;	&lt;b&gt;Prolonged visualization of malignant nodules-&amp;gt; inte&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="24"&gt;	&lt;b&gt;Vascular, kupffer&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="24"&gt;	&lt;b&gt;rvention guidance for liver lesions&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Kupffer Cell Image in CE-EUS
Prolonged visualization of malignant nodules-&gt; increased detectability &amp; aid for intervention in liver</text>
		</slide>
		<slide index="24" title="Contrast-enhanced harmonic image" titleNormalized="contrast-enhanced harmonic image" src="slide25.swf" size="22411" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset24" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="26.1410002"/>
			</animationSteps>
			<notes>
			</notes>
			<notesNormalized/>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt; &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Contrast-enhanced harmonic image
Kupffer image in contrast-enhanced US remarkably increased the detectability of liver lesions, compared with B-mode US.

The accuracy of diagnosis of liver metastases under contrast-enhanced US has been reported to be more than 90%.
Sugimoto K, et al. Acad Radiol 2009
Dietrich CF, et al. World J Gastroenterol 2006</text>
		</slide>
		<slide index="25" title="CH-EUS guided Liver FNA (AMC data)" titleNormalized="ch-eus guided liver fna (amc data)" src="slide26.swf" size="42272" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset25" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="32.7680010"/>
			</animationSteps>
			<notes>1)	Inclusion criteria
2)	Exclusion criteria</notes>
			<notesNormalized>1)	inclusion criteria
2)	exclusion criteria</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;1)	Inclusion criteria&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;2)	Exclusion criteria&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CH-EUS guided Liver FNA (AMC data)
 Between Sep 2010 and Nov 2016
A single center retrospective study
Clinical utility of CE-EUS guided liver FNA
Thirty consecutive pts with hepatic masses underwent CE-EUS guided liver FNA
B-mode EUS followed by CE-EUS guided FNA
</text>
		</slide>
		<slide index="26" title="Classification of EUS findings before contrast enhancement" titleNormalized="classification of eus findings before contrast enhancement" src="slide27.swf" size="60501" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset26" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="11.2470001"/>
			</animationSteps>
			<notes>1)	Inclusion criteria
2)	Exclusion criteria</notes>
			<notesNormalized>1)	inclusion criteria
2)	exclusion criteria</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;1)	Inclusion criteria&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;2)	Exclusion criteria&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Classification of EUS findings before contrast enhancement</text>
		</slide>
		<slide index="27" title="RESULTS (I)" titleNormalized="results (i)" src="slide28.swf" size="5617" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset27" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.3469996"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>RESULTS (I)
Variables
B-mode EUS
CE-EUS
Lesion identification
22 (73.3%)
29 (96.7%)
 Suspected
8 (26.7%)
1 (3.3%)
 Faintly visible
15 (50%)
0
 Clearly visible 
7 (23.3%)
29 *96.7%)
Visuality score, median
2 (1-2.25)
3 (3-3)
Visualization of Hepatic lesions with CE-EUS</text>
		</slide>
		<slide index="28" title="RESULTS (II)" titleNormalized="results (ii)" src="slide29.swf" size="4908" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset28" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.1930002"/>
			</animationSteps>
			<notes>The diagnostic accuracy of CH EUS guided FNA was 97%</notes>
			<notesNormalized>the diagnostic accuracy of ch eus guided fna was 97%</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The diagnostic accuracy of CH EUS guided FNA was 97%&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Sensitivity
Specificity
Diagnostic accuracy
CE-EUS
78.6% 
100% 
80%
CE-EUS + CE-EUS guided FNA
96.4% 
100% 
97%
RESULTS (II)
The sensitivity and specificity of CE-EUS</text>
		</slide>
		<slide index="29" title="RESULTS (III)" titleNormalized="results (iii)" src="slide30.swf" size="5690" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset29" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="40.9290003"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Variables
SonVueTM 
(n=16)
SonazoidTM 
(n=14)
Lesion identification
15 (93.8%)
14 (100%)
Adequacy
14 (87.5%)
14 (100%)
Diagnostic accuracy
15 (93.8%)
14 (100%)
Number of needle pass
3 (IQR 3-4)
2.5 (IQR 1-3)
RESULTS (III)
Comparison of contrast agents</text>
		</slide>
		<slide index="30" title="46-y/o-male, suspected pancreatic cancer with liver metastasis" titleNormalized="46-y/o-male, suspected pancreatic cancer with liver metastasis" src="slide31.swf" size="210219" advanceOnTime="1" framesCount="1574" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset30" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video2" videoClipId="ispring.resources_17e547f0.spr0_5261383" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_17e547f0.spr2_5261383" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video2" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="1573" playTime="65.4570007" pauseTime="0.0000000"/>
			</animationSteps>
			<notes>B mode EUS shows subtle heterogeneous echogenicity, but it is not clear.
After contrast inj,  multiple hypoenhanced mass were clearly visualized. Therefore, FNA can be easily performed.
CHEUS is preferred tech in cases with pancreatic and liver lesions</notes>
			<notesNormalized>b mode eus shows subtle heterogeneous echogenicity, but it is not clear.
after contrast inj, multiple hypoenhanced mass were clearly visualized. therefore, fna can be easily performed.
cheus is preferred tech in cases with pancreatic and liver lesions</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;B mode EUS shows subtle heterogeneous echogenicity, but it is not clear.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;After contrast inj,  multiple hypoenhanced mass were clearly visualized. Therefore, FNA can be easily performed.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;CHEUS is preferred tech in cases with pancreatic and liver lesions&lt;/font&gt;&lt;/p&gt;</notesHtml>
		</slide>
		<slide index="31" title="CE-EUS guided Liver FNA" titleNormalized="ce-eus guided liver fna" src="slide32.swf" size="38743" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset31" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="12.7269997"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>CE-EUS guided Liver FNA
CE-EUS guided FNA can result in a high diagnostic accuracy in cases where the hepatic lesions are poorly visible on B-mode EUS.</text>
		</slide>
		<slide index="32" title="Limitation of CE-EUS guided FNA" titleNormalized="limitation of ce-eus guided fna" src="slide33.swf" size="2550" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset32" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="16.7420000"/>
			</animationSteps>
			<notes>Helpful in selected cases as a problem-solving tool</notes>
			<notesNormalized>helpful in selected cases as a problem-solving tool</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12" color="#000000"&gt;&lt;b&gt;Helpful in selected cases &lt;/font&gt;&lt;font size="12" color="#ffff00"&gt;as a problem-solving tool&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Limitation of CE-EUS guided FNA
Affected by sonic attenuation (deep seated lesion, severe fatty liver).
Penetration of US beam with CE-EUS is inferior.</text>
		</slide>
		<slide index="33" title="Conclusion" titleNormalized="conclusion" src="slide34.swf" size="3144" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset33" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="23.9280009"/>
			</animationSteps>
			<notes>EUS may be more sensitive for identifying smaller liver lesions.
EUS-FNA  is possible to perform diagnostic assessment and could improve tumor stating as well as tissue acquisition.
EUS-FNA can be used as a rescue method in cases where the percutaneous approach failed.</notes>
			<notesNormalized>eus may be more sensitive for identifying smaller liver lesions.
eus-fna is possible to perform diagnostic assessment and could improve tumor stating as well as tissue acquisition.
eus-fna can be used as a rescue method in cases where the percutaneous approach failed.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12" color="#000000"&gt;&lt;b&gt;EUS may be more sensitive for identifying smaller liver lesions.&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12" color="#000000"&gt;&lt;b&gt;EUS-FNA  is possible to perform diagnostic assessment and could improve tumor stating as well as tissue acquisition.&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12" color="#000000"&gt;&lt;b&gt;EUS-FNA can be used as a rescue method in cases where the percutaneous approach failed.&lt;/font&gt;&lt;font size="12" color="#ffff00"&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Conclusion
More sensitive for identifying smaller liver lesions.
EUS-FNA is possible to perform diagnostic assessment and could improve tumor staging as well as tissue acquisition.
A rescue method in cases where the percutaneous approach failed or contraindicated.</text>
		</slide>
		<slide index="34" title="Conclusion" titleNormalized="conclusion" src="slide35.swf" size="3177" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset34" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="26.2870001"/>
			</animationSteps>
			<notes>Helpful in selected cases as a problem-solving tool</notes>
			<notesNormalized>helpful in selected cases as a problem-solving tool</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12" color="#000000"&gt;&lt;b&gt;Helpful in selected cases &lt;/font&gt;&lt;font size="12" color="#ffff00"&gt;as a problem-solving tool&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Conclusion
One session of EUS-FNA for suspected pancreatic and liver lesions.
Increases the detectability of inconspicuous liver mass on B-mode EUS.
A problem-solving tool in cases where conventional EUS had failed to localize the tumor. 
</text>
		</slide>
	</slides>
</presentation>
